Global revenues from infant ventilators, jaundice management products, and neonatal and perinatal monitoring technologies reached $706 million in 2013. Explored in LSI's report, the market for these technologies will develop as a result of the global forces that are affecting the status of neonatal care, which include powerful regional and demographic trends; the transformation of institutional healthcare in emerging markets; trends in information technology and connectivity; and marketing and manufacturing efforts among device suppliers. Unfolding developments in national systems, such as systemic reforms and efforts to control rising costs, will also have important effects.
Critical Issues Covered in this Report:
• The competitive landscape for these devices in the U.S. and international markets;
• Quantitative factors including pricing, replacement rates, new units, and aftermarket revenues; and
• Birth rates as well as other key infrastructure and market metrics.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
